NCT00358631View on ClinicalTrials.gov

An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

319

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Depressive Disorder
Interventions
DRUG

SSR149415

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY